Treatment News : People With HIV Have a Doubled Risk of Non-Melanoma Skin Cancers

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » February 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


February 6, 2013

People With HIV Have a Doubled Risk of Non-Melanoma Skin Cancers

The incidence of two non-melanoma skin cancers—basal cell and squamous cell carcinomas—is more than twice as high among people with HIV as compared with the general population, according to study findings published in the Journal of the National Cancer Institute and reported by Kaiser Permanente, which conducted the research. The study included a cohort of 6,560 HIV-positive and nearly 37,000 HIV-negative members of Kaiser Permanente Northern California between 1996 and 2008.

The study, which is the first to identify with such specificity the nature of this increased skin cancer risk, found that the HIV-positive participants’ rate of basal cell carcinomas was 2.1 times higher than those without HIV, and their risk of squamous cell carcinomas 2.6 times greater. The researchers also found that squamous cell carcinomas were associated with lowered CD4 counts. The study’s authors note these findings fall in line with HIV-positive people’s increased risk for a wide variety of cancers, which is likely a consequence of damage to the immune system.

In press materials, senior author Maryam M. Asgari, MD, MPH, a Kaiser Permanente dermatologist and investigator at its Division of Research, called for “increased vigilance in skin-cancer screening for HIV-positive individuals” for these common and typically curable cancers, “particularly for those who are not on antiretroviral therapy or who were diagnosed late and have more advanced HIV/AIDS.”

To read the Kaiser Permanente release, click here.

For the study abstract, click here.

Search: HIV, skin cancer, non-melanoma, basal cell, squamous cell, carcinoma, ournal of the National Cancer Institute, Kaiser Permanente, Maryam M. Asgari.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Has a pet helped you deal with your HIV?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.